Showing results (801-810 of 1,005) with videos related to

Sort By:
Pageof 101
Blood Cells, Molecules & Diseases|December 20, 2020
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuriaCarmelo Gurnari, Amy C Graham, Alexey Efanov, et al.
Investigational New Drugs|September 18, 1998
Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignanciesH A Burris, E Raymond, A Awada, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Development of NanoBRET cellular target engagement assays in primary neurons for activating mutants of p21-activated kinase 1Jacob L Capener, Abdiel Badillo-Martinez, Bassel Awada, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2012
Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumoursAhmad Awada, Alain Hendlisz, Olaf Christensen, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2008
Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patientsJürgen B Bulitta, Ping Zhao, Robert D Arnold, et al.
Cancer Chemotherapy and Pharmacology|December 10, 2015
A phase I study of two dosing schedules of oral BI 847325 in patients with advanced solid tumorsPatrick Schöffski, Philippe Aftimos, Herlinde Dumez, et al.
Cancers|February 15, 2022
Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical TrialJulia Katharina Schwarze, Soizic Garaud, Yanina J L Jansen, et al.
Acta Oncologica (Stockholm, Sweden)|December 17, 2022
Days alive and out of hospital following primary surgery for oral cavity squamous cell carcinomaHussein Nasser Awada, Mikkel Holm Larsen, Eva Kristine Ruud Kjær, et al.
British Journal of Cancer|November 3, 2011
TYRP1 mRNA expression in melanoma metastases correlates with clinical outcomeF Journe, H Id Boufker, L Van Kempen, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2008
Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patientsJürgen B Bulitta, Ping Zhao, Robert D Arnold, et al.
Pageof 101